Category Archives: Top Market News

Thursday’s Midday Stock Update: Orexigen (OREX), Anthera Pharmaceuticals (ANTH), American Green Inc (ERBB), Curis Inc (CRIS), Uni-Pixel (UNXL)

So far Thursday, December 13, NASDAQ is down -4.32% and the S&P is down -1.44%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Orexigen (OREX – Research Report), Anthera Pharmaceuticals (ANTH – Research

Adial Pharmaceuticals Inc (ADIL) Gets a Buy Rating from Maxim Group

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Adial Pharmaceuticals Inc (ADIL – Research Report), with a price target of $5. The company’s shares opened today at $2.88. McCarthy said: “Adial announced that

H.C. Wainwright Remains a Buy on Omeros Corp (OMER)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Omeros Corp (OMER – Research Report) today and set a price target of $34. The company’s shares closed yesterday at $14.35. Selvaraju noted: “Valuation methodology, risks and uncertainties. We currently

Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX) and AVEO Pharma (NASDAQ: AVEO)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neurocrine (NBIX – Research Report) and AVEO Pharma (AVEO – Research Report) with bullish sentiments. Neurocrine (NBIX) H.C. Wainwright analyst Andrew Fein

Autodesk (ADSK) was Downgraded to a Hold Rating at J.P. Morgan

In a report released today, Sterling Auty from J.P. Morgan downgraded Autodesk (ADSK – Research Report) to Hold. The company’s shares closed yesterday at $137.79. According to TipRanks.com, Auty is a 5-star analyst with an average return of 12.1% and

nLIGHT Inc (LASR) Gets a Sell Rating from Benchmark Co.

Benchmark Co. analyst Mark Miller reiterated a Sell rating on nLIGHT Inc (LASR – Research Report) today and set a price target of $14. The company’s shares closed yesterday at $19.54, close to its 52-week low of $16.25. According to